Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,667 across all filing types
Latest filing 2011-06-14 Share Issue/Capital Cha…
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Appendix 3B 8 pages 121.9KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 3B form submitted to the Australian Stock Exchange (ASX) announcing the exercise of options and the allotment of ordinary shares. It details the number of securities issued, exercise price, terms, and the application for quotation of these additional securities on the ASX. The document is a regulatory announcement about a capital change event (exercise of options and new shares issued). It is not a financial report, earnings release, or management discussion. It is specifically an announcement of a new issue of shares and related securities, consistent with a Share Issue/Capital Change filing. The document length and content confirm it is the actual announcement, not just a brief notice or a report publication announcement.
2011-06-14 English
Takeover Notice to Target 2 pages 138.1KB
M&A Activity Classification · 95% confidence The document is an announcement to the Australian Stock Exchange regarding an off-market takeover bid by bioMD Limited for Allied Medical Limited. It includes details about the voting power rising above 90% and interim figures of share acceptances. The content focuses on takeover bid progress and shareholding percentages, which aligns with announcements related to merger or acquisition activities. The document is not a full merger filing or proxy statement but an update on the takeover bid status. Therefore, the most appropriate classification is M&A Activity (TAR). The document length is short and it is not a report publication announcement or regulatory filing. Confidence is high due to clear references to takeover bid and voting power changes.
2011-06-13 English
Results of Extraordinary General Meeting 1 page 86.
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'RESULTS OF GENERAL MEETING' and is addressed as an announcement to the Australian Stock Exchange. It details the voting results of resolutions passed at a general meeting held on 10 June 2011, including votes for, against, abstain, and proxy discretion. There is no financial data, management discussion, or detailed report content. The document is short (1656 characters) and focuses solely on the official results of shareholder votes at a general meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2011-06-09 English
Market Update - Progress Tissue Heart Valve Study 2 pages 192.8KB
Capital/Financing Update Classification · 90% confidence The document is an ASX market update release from bioMD Limited dated June 3, 2011, describing progress on a tissue heart valve feasibility study. It provides detailed information about the study phases, aims, outcomes to date, and expected results. The document is relatively short (4604 characters) and is presented as a market update rather than a full financial or regulatory report. It does not contain financial statements, audit information, or detailed management discussion and analysis. It is not an earnings release or an annual/interim report. The content focuses on progress updates related to a specific research study, which aligns with a Capital/Financing Update or a general Market Update. Given the ASX release format and the nature of the content, the best fitting category is Capital/Financing Update (CAP), as it relates to progress on a project that could impact company valuation and financing considerations. Confidence is high due to clear labeling as an ASX release and detailed project update.
2011-06-02 English
Takeover Notice to Target 75% 2 pages 135.9KB
M&A Activity Classification · 95% confidence The document is an announcement to the Australian Stock Exchange regarding an off-market takeover bid by bioMD Limited for Allied Medical Limited. It includes details about voting power exceeding 75%, share acceptances, and percentage of shares acquired. The content focuses on takeover bid progress and shareholding changes rather than financial results, management changes, or regulatory certifications. The document length is short (2151 characters) and it is an announcement rather than a full report. This fits the category of M&A Activity (TAR) as it relates to merger proposals and takeover bids.
2011-05-30 English
Takeover Notice to Target 50% 2 pages 136.1KB
M&A Activity Classification · 95% confidence The document is an announcement to the Australian Stock Exchange regarding an off-market takeover bid by bioMD Limited for Allied Medical Limited. It includes details about voting power rising above 50%, indicative figures of share acceptances, and percentage of shares acquired. The content focuses on takeover bid activity and shareholding changes rather than financial results, management changes, or regulatory certifications. The document length is short (2153 characters) and it is an announcement of a takeover bid status and shareholding update. This fits the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids.
2011-05-25 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.